Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Cancer Treatment Centers of America
Distinguished surgical oncologist offers advanced treatment options for gastrointestinal malignancies
CHICAGO, Jan. 6, 2014 /PRNewswire-USNewswire/ -- Cancer Treatment Centers of America (CTCA) at Midwestern Regional Medical Center (Midwestern) is proud to announce that Juan Sanabria, MD, MSc, FRCSC, FACS, has joined the hospital as a surgical oncologist focusing on the treatment of gastrointestinal malignancies including liver cancer, pancreatic cancer, gall bladder cancer and kidney cancer. Originally from Bogotá, Columbia, Dr. Sanabria earned his medical degree from the Colegio Mayor de Ntra Sra del Rosario in addition to completing the MD International Medical Graduate Program at the University of Toronto, St Michael's Hospital. Dr. Sanabria also completed a fellowship in the Epidemiology Unit G.I. Cancer Registry at Mount Sinai Hospital, as well as a fellowship in the HPB and Transplant Surgery Multi-Organ Transplant Unit at the University of Toronto.
"We are excited to welcome Dr. Sanabria to the CTCA team," said C. Komen Brown, MD, PhD, national director for peritoneal surface malignancies and hyperthermic intraperitoneal chemotherapy, chief of surgery at CTCA at Midwestern. "He is an exceptional surgeon with considerable experience treating GI cancer. He is also committed to discovering new ways to enhance patient recovery."
As part of the CTCA at Midwestern team, Dr. Sanabria will consult with medical oncologists and patients on surgical treatment options, perform leading-edge surgical procedures, and monitor patients who may need surgical intervention in the future.
"It is a privilege to join CTCA and contribute to their fully integrated and patient centered approach to care," said Dr. Sanabria. "A true physician is not only a counselor, an educator, but also an innovator who exercises the highest standards of care."
Doctor Sanabria is an active member of the Society of American Gastrointestinal and Endoscopic Surgeons and has authored countless manuscripts. He previously served as the Director of Pancreas Transplant at University Hospitals Case Medical Center in Cleveland, OH. Additionally, he served as an Assistant Professor of Surgery and an Assistant Professor of Nutrition and Metabolism at Case WR University School of Medicine.
For more information on CTCA at Midwestern, visit www.cancercenter.com.
About Cancer Treatment Centers of America at Midwestern Regional Medical Center
Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center is a 73 bed specialty hospital dedicated to treating patients battling complex cancer. CTCA® at Midwestern is nationally recognized for providing innovative and individualized cancer care and has been designated by the American Nurses Credentialing Center (ANCC) a Magnet Recognized® program, ranking the hospital as one of the top seven percent in the nation for nursing excellence. CTCA at Midwestern has been designated by the National Quality Measures for Breast Centers Program (NQMBC®) as a Certified Quality Breast Center of Excellence™, ranking the hospital among the top centers in the country for quality breast cancer care. CTCA at Midwestern is the only Certified Breast Center of Excellence in Illinois, and one of only 41 nationally. As a member of the National Marrow Donor Program (NMDP) the hospital also offers a Stem Cell Transplant and Cell Therapy program that provides a full spectrum of transplantation services and advanced treatment options for hematologic cancers. CTCA at Midwestern is proud to use the latest technology to offer advanced treatment for cancer and is currently one of only a few hospitals in the nation to combine recent advances in brain mapping and navigation to perform minimally invasive brain surgery on hard to reach brain tumors.
©2012 PR Newswire. All Rights Reserved.